Mikrobiom a choroby skóry

GLOSA LUB KOMENTARZ PRAWNICZY

Mikrobiom a choroby skóry

Dorota Mańkowska-Wierzbicka 1 , Jacek Karczewski 1 , Agnieszka Dobrowolska-Zachwieja 1 , Zygmunt Adamski 1

1. Poznan University of Medical Sciences in Poznan, Poznan, Poland

Opublikowany: 2015-09-07
GICID: 01.3001.0009.6568
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2015; 69 : 978-985

 

Abstrakt

Przypisy

  • 1. Abrahamsson T.R., Jakobsson H.E., Andersson A.F., Björkstén B.,Engstrand L., Jenmalm M.C.: Low diversity of the gut microbiotain infants with atopic eczema. J. Allergy Clin. Immunol., 2012; 129:434-440
    Google Scholar
  • 2. Arck P., Handjiski B., Hagen E., Pincus M., Bruenahl C., BienenstockJ., Paus R.: Is there a ‘gut-brain-skin axis’? Exp. Dermatol.,2010; 19: 401-405
    Google Scholar
  • 3. Artis D.: Epithelial-cell recognition of commensal bacteria andmaintenance of immune homeostasis in the gut. Nat. Rev. Immunol.,2008; 8: 411-420
    Google Scholar
  • 4. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., NishikawaH., Fukuda S., Saito T., Narushima S., Hase K., Kim S., Fritz J.V., WilmesP., Ueha S., Matsushima K. et al.: Treg induction by a rationallyselected mixture of Clostridia strains from the human microbiota.Nature, 2013; 500: 232-236
    Google Scholar
  • 5. Azukizawa H., Döhler A., Kanazawa N., Nayak A., Lipp M., MalissenB., Autenrieth I., Katayama I., Riemann M., Weih F., Berberich–Siebelt F., Lutz M.B.: Steady state migratory RelB+ langerin+ dermaldendritic cells mediate peripheral induction of antigen-specific CD4+CD25+ Foxp3+ regulatory T cells. Eur. J. Immunol., 2011; 41: 1420-1434
    Google Scholar
  • 6. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., SemenkovichC.F., Gordon J.I.: The gut microbiota as an environmentalfactor that regulates fat storage. Proc. Natl. Acad. Sci. USA, 2004;101: 15718-15723
    Google Scholar
  • 7. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I.:Host-bacterial mutualism in the human intestine. Science, 2005;307: 1915-1920
    Google Scholar
  • 8. Bager P., Wohlfahrt J., Westergaard T.: Caesarean delivery andrisk of atopy and allergic disease: meta-analyses. Clin. Exp. Allergy,2008; 38: 634-642
    Google Scholar
  • 9. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., CaminschiI., Allan R.S., Wojtasiak M., Shortman K., Carbone F.R., BrooksA.G., Heath W.R.: Cross-presentation of viral and self antigens byskin-derived CD103+ dendritic cells. Nat. Immunol., 2009; 10: 488-495
    Google Scholar
  • 10. Belkaid Y., Naik S.: Compartmentalized and systemic control oftissue immunity by commensals. Nat. Immunol., 2013; 14: 646-653
    Google Scholar
  • 11. Berg R.D.: The indigenous gastrointestinal microflora. TrendsMicrobiol., 1996; 4: 430-435
    Google Scholar
  • 12. Borkowski A.W., Gallo R.L.: The coordinated response of thephysical and antimicrobial peptide barriers of the skin. J. Invest.Dermatol., 2011; 131: 285-287
    Google Scholar
  • 13. Bowe W., Patel N.B., Logan A.C.: Acne vulgaris, probiotics andthe gut-brain-skin axis: from anecdote to translational medicine.Benef. Microbes, 2014; 5: 185-199
    Google Scholar
  • 14. Braff M.H., Gallo R.L.: Antimicrobial peptides: an essential componentof the skin defensive barrier. Curr. Top. Microbiol. Immunol.,2006; 306: 91-110
    Google Scholar
  • 15. Cebra J.J.: Influences of microbiota on intestinal immune systemdevelopment. Am. J. Clin. Nutr., 1999; 69: 1046S-1051S
    Google Scholar
  • 16. Cho I., Blaser M.J.: The human microbiome: at the interface ofhealth and disease. Nat. Rev. Genet., 2012; 13: 260-270
    Google Scholar
  • 17. Cogen A.L., Yamasaki K., Sanchez K.M., Dorschner R.A., Lai Y.,MacLeod D.T., Torpey J.W., Otto M., Nizet V., Kim J.E., Gallo R.L.: Selectiveantimicrobial action is provided by phenol-soluble modulinsderived from Staphylococcus epidermidis, a normal resident of the skin.J. Invest. Dermatol., 2010; 130: 192-200
    Google Scholar
  • 18. Costello E.K., Lauber C.L., Hamady M., Fierer N., Gordon J.I.,Knight R.: Bacterial community variation in human body habitatsacross space and time. Science, 2009; 326: 1694-1697
    Google Scholar
  • 19. de Jongh G.J., Zeeuwen P.L., Kucharekova M., Pfundt R., van derValk P.G., Blokx W., Dogan A., Hiemstra P.S., van de Kerkhof P.C.,Schalkwijk J.: High expression levels of keratinocyte antimicrobialproteins in psoriasis compared with atopic dermatitis. J. Invest.Dermatol., 2005; 125: 1163-1173
    Google Scholar
  • 20. Dessinioti C., Katsambas A.D.: The role of Propionibacterium acnesin acne pathogenesis: facts and controversies. Clin. Dermatol.,2010; 28: 2-7
    Google Scholar
  • 21. Dominguez-Bello M.G., Costello E.K., Contreras M., Magris M.,Hidalgo G., Fierer N., Knight R.: Delivery mode shapes the acquisitionand structure of the initial microbiota across multiple body habitatsin newborns. Proc. Natl. Acad. Sci. USA, 2010; 107: 11971-11975
    Google Scholar
  • 22. Dudda J.C., Perdue N., Bachtanian E., Campbell D.J.: Foxp3+ regulatoryT cells maintain immune homeostasis in the skin. J. Exp.Med., 2008; 205: 1559-1565
    Google Scholar
  • 23. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L.,Sargent M., Gill S.R., Nelson K.E., Relman D.A.: Diversity of the humanintestinal microbial flora. Science, 2005; 308: 1635-1638
    Google Scholar
  • 24. Findley K., Oh J., Yang J., Conlan S., Deming C., Meyer J.A., SchoenfeldD., Nomicos E., Park M., NIH Intramural Sequencing CenterComparative Sequencing Program, Kong H.H., Segre J.A.: Topographicdiversity of fungal and bacterial communities in human skin.Nature, 2013; 498: 367-370
    Google Scholar
  • 25. Friswell M.K., Gika H., Stratford I.J., Theodoridis G., Telfer B.,Wilson I.D., McBain A.J.: Site and strain-specific variation in gutmicrobiota profiles and metabolism in experimental mice. PLoSOne, 2010; 5: e8584
    Google Scholar
  • 26. Fry L., Baker B.S., Powles A.V., Fahlen A., Engstrand L.: Is chronicplaque psoriasis triggered by microbiota in the skin? Br. J. Dermatol.,2013; 169: 47-52
    Google Scholar
  • 27. Gallo R.L., Nakatsuji T.: Microbial symbiosis with the innateimmune defense system of the skin. J. Invest. Dermatol., 2011; 131:1974-1980
    Google Scholar
  • 28. Gao Z., Tseng C.H., Strober B.E., Pei Z., Blaser M.J.: Substantialalterations of the cutaneous bacterial biota in psoriatic lesions. PLoSOne, 2008; 3: e2719
    Google Scholar
  • 29. Grice E.A., Kong H.H., Renaud G., Young A.C.; NISC ComparativeSequencing Program; Bouffard G.G., Blakesley R.W., Wolfsberg T.G.,Turner M.L., Segre J.A.: A diversity profile of the human skin microbiota.Genome Res., 2008; 18: 1043-1050
    Google Scholar
  • 30. Grice E.A., Segre J.A.: The skin microbiome. Nat. Rev. Microbiol.,2011; 9: 244-253
    Google Scholar
  • 31. Gudjonsson J.E., Ding J., Li X., Nair R.P., Tejasvi T., Qin Z.S., GhoshD., Aphale A., Gumucio D.L., Voorhees J.J., Abecasis G.R., Elder J.T.:Global gene expression analysis reveals evidence for decreased lipidbiosynthesis and increased innate immunity in uninvolved psoriaticskin. J. Invest. Dermatol., 2009; 129: 2795-2804
    Google Scholar
  • 32. Harder J., Dressel S., Wittersheim M., Cordes J., Meyer-Hoffert U.,Mrowietz U., Fölster-Holst R., Proksch E., Schröder J.M., Schwarz T.,Gläser R.: Enhanced expression and secretion of antimicrobial peptidesin atopic dermatitis and after superficial skin injury. J. Invest.Dermatol., 2010; 130: 1355-1364
    Google Scholar
  • 33. Hill D.A., Artis D.: Intestinal bacteria and the regulation of immunecell homeostasis. Ann. Rev. Immunol., 2010; 28: 623-667
    Google Scholar
  • 34. Holmes A.D.: Potential role of microorganisms in the pathogenesisof rosacea. J. Am. Acad. Dermatol., 2013; 69: 1025-1032
    Google Scholar
  • 35. Honda K., Littman D.R.: The microbiome in infectious diseaseand inflammation. Annu. Rev. Immunol., 2012; 30: 759-795
    Google Scholar
  • 36. Hong P.Y., Lee B.W., Aw M., Shek L.P., Yap G.C., Chua K.Y., LiuW.T.: Comparative analysis of fecal microbiota in infants with andwithout eczema. PLoS One, 2010; 5: e9964
    Google Scholar
  • 37. Hooper L.V., Midtvedt T., Gordon J.I.: How host-microbial interactionsshape the nutrient environment of the mammalian intestine.Annu. Rev. Nutr., 2002; 22: 283-307
    Google Scholar
  • 38. Hughes S., Williams S.E., Turnberg R.A.: Crohn’s disease andpsoriasis. N. Engl. J. Med., 1983; 308: 101
    Google Scholar
  • 39. Iwase T., Uehara Y., Shinji H., Tajima A., Seo H., Takada K., AgataT., Mizunoe Y.: Staphylococcus epidermidis Esp inhibits Staphylococcusaureus biofilm formation and nasal colonization. Nature, 2010;465: 346-349
    Google Scholar
  • 40. Jugeau S., Tenaud I., Knol A.C., Jarrousse V., Quereux G., KhammariA., Dreno B.: Induction of toll-like receptors by Propionibacteriumacnes. Br. J. Dermatol., 2005; 153: 1105-1113
    Google Scholar
  • 41. Lai Y., Cogen A.L., Radek K.A., Park H.J., Macleod D.T., LeichtleA., Ryan A.F., Di Nardo A., Gallo R.L.: Activation of TLR2 by a smallmolecule produced by Staphylococcus epidermidis increases antimicrobialdefense against bacterial skin infections. J. Invest. Dermatol.,2010; 130: 2211-2221
    Google Scholar
  • 42. Lai Y., Di Nardo A., Nakatsuji T., Leichtle A., Yang Y., Cogen A.L.,Wu Z.R., Hooper L.V., Schmidt R.R., von Aulock S., Radek K.A., Huang C.M., Ryan A.F., Gallo R.L.: Commensal bacteria regulate Toll-likereceptor 3-dependent inflammation after skin injury. Nat. Med.,2009; 15: 1377-1382
    Google Scholar
  • 43. Ley R.E., Peterson D.A., Gordon J.I.: Ecological and evolutionaryforces shaping microbial diversity in the human intestine. Cell,2006; 124: 837-848
    Google Scholar
  • 44. Li W.Q., Han J.L., Chan A.T., Qureshi A.A.: Psoriasis, psoriatic arthritisand increased risk of incident Crohn’s disease in US women.Ann. Rheum. Dis., 2013; 72: 1200-1205
    Google Scholar
  • 45. Maintz L., Novak N.: Modifications of the innate immune systemin atopic dermatitis. J. Innate Immun., 2011; 3: 131-141
    Google Scholar
  • 46. Manichanh C., Borruel N., Casellas F., Guarner F.: The gut microbiotain IBD. Nat. Rev. Gastroenterol. Hepatol., 2012; 9: 599-608
    Google Scholar
  • 47. Marks R.: Concepts in the pathogenesis of rosacea. Br. J. Dermatol.,1968; 80: 170-177
    Google Scholar
  • 48. Melgar S., Shanahan F.: Inflammatory bowel disease – from mechanismsto treatment strategies. Autoimmunity, 2010; 43: 463-477
    Google Scholar
  • 49. Moore W.E., Moore L.H.: Intestinal floras of populations thathave a high risk of colon cancer. Appl. Environ. Microbiol., 1995;61: 3202-3207
    Google Scholar
  • 50. Nagano Y., Itoh K., Honda K.: The induction of Treg cells bygut-indigenous Clostridium. Curr. Opin. Immunol., 2012; 24: 392-397
    Google Scholar
  • 51. Naik S., Bouladoux N., Wilhelm C., Molloy M.J., Salcedo R., KastenmullerW., Deming C., Quinones M., Koo L., Conlan S., SpencerS., Hall J.A., Dzutsev A., Kong H., Campbell D.J., Trinchieri G., SegreJ.A., Belkaid Y.: Compartmentalized control of skin immunity byresident commensals. Science, 2012; 337: 1115-1119
    Google Scholar
  • 52. Nijnik A., Hancock R.E.: The roles of cathelicidin LL-37 in immunedefences and novel clinical applications. Curr. Opin. Hematol.,2009; 16: 41-47
    Google Scholar
  • 53. Noble W.C., Somerville D.A.: Microbiology of Human Skin. London:W.B. Saunders, 1974
    Google Scholar
  • 54. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., HallC.F., Darst M.A., Gao B., Boguniewicz M., Travers J.B., Leung D.Y.:Cytokine milieu of atopic dermatitis, as compared to psoriasis, skinprevents induction of innate immune response genes. J. Immunol.,2003; 171: 3262-3269
    Google Scholar
  • 55. Ochoa-Repáraz J., Mielcarz D.W., Begum-Haque S., Kasper L.H.:Gut, bugs, and brain: role of commensal bacteria in the control ofcentral nervous system disease. Ann. Neurol., 2011; 69: 240-247
    Google Scholar
  • 56. Ojetti V., De Simone C., Aguilar Sanchez J., Capizzi R., MignecoA., Guerriero C., Cazzato A., Gasbarrini G., Amerio P., Gasbarrini A.:Malabsorption in psoriatic patients: cause or consequence? Scand.J. Gastroenterol., 2006; 41: 1267-1271
    Google Scholar
  • 57. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., GanzT., Gallo R.L., Leung D.Y.: Endogenous antimicrobial peptides and skininfections in atopic dermatitis. N. Engl. J. Med., 2002; 347: 1151-1160
    Google Scholar
  • 58. Owen C.M., Chalmers R.J., O’Sullivan T., Griffiths C.E.: A systematicreview of antistreptococcal interventions for guttate and chronicplaque psoriasis. Br. J. Dermatol., 2001; 145: 886-890
    Google Scholar
  • 59. Penders J., Gerhold K., Stobberingh E.E., Thijs C., ZimmermannK., Lau S., Hamelmann E.: Establishment of the intestinal microbiotaand its role for atopic dermatitis in early childhood. J. Allergy Clin.Immunol. 2013; 132: 601-607.e8
    Google Scholar
  • 60. Pivarcsi A., Kemény L., Dobozy A.: Innate immune functionsof the keratinocytes. A review. Acta Microbiol. Immunol. Hung.,2004; 51: 303-310
    Google Scholar
  • 61. Proal A.D., Albert P.J., Marshall T.G.: The human microbiome andautoimmunity. Curr. Opin. Rheumatol., 2013; 25: 234-240
    Google Scholar
  • 62. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., GuanY., Shen D., Peng Y., Zhang D., Jie Z., Wu W., Qin Y. et al.: A metagenome-wideassociation study of gut microbiota in type 2 diabetes.Nature, 2012; 490: 55-60
    Google Scholar
  • 63. Roth R.R., James W.D.: Microbial ecology of the skin. Annu. Rev.Microbiol., 1988; 42: 441-464
    Google Scholar
  • 64. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., MazmanianS.K.: The Toll-like receptor 2 pathway establishes colonizationby a commensal of the human microbiota. Science, 2011; 332: 974-977
    Google Scholar
  • 65. Round J.L., Mazmanian S.K.: The gut microbiota shapes intestinalimmune responses during health and disease. Nat. Rev. Immunol.,2009; 9: 313-323
    Google Scholar
  • 66. Round J.L., Mazmanian S.K.: Inducible Foxp3+ regulatory T-celldevelopment by a commensal bacterium of the intestinal microbiota.Proc. Natl. Acad. Sci. USA, 2010; 107: 12204-11209
    Google Scholar
  • 67. Sather B.D., Treuting P., Perdue N., Miazgowicz M., FontenotJ.D., Rudensky A.Y., Campbell D.J.: Altering the distribution of Foxp3+regulatory T cells results in tissue-specific inflammatory disease. J.Exp. Med., 2007; 204: 1335-1347
    Google Scholar
  • 68. Scher J.U., Abramson S.B.: The microbiome and rheumatoidarthritis. Nat. Rev. Rheumatol., 2011; 7: 569-578
    Google Scholar
  • 69. Sekirov I., Tam N.M., Jogova M., Robertson M.L., Li Y., Lupp C.,Finlay B.B.: Antibiotic-induced perturbations of the intestinal microbiotaalter host susceptibility to enteric infection. Infect. Immun.,2008; 76: 4726-4736
    Google Scholar
  • 70. Sellitto M., Bai G., Serena G., Fricke W.F., Sturgeon C., Gajer P.,White J.R., Koenig S.S., Sakamoto J., Boothe D., Gicquelais R., KryszakD., Puppa E., Catassi C., Ravel J., Fasano A.: Proof of conceptof microbiome-metabolome analysis and delayed gluten exposureon celiac disease autoimmunity in genetically at-risk infants. PLoSOne, 2012; 7: e33387
    Google Scholar
  • 71. Seneschal J., Clark R.A., Gehad A., Baecher-Allan C.M., KupperT.S.: Human epidermal Langerhans cells maintain immune homeostasisin skin by activating skin resident regulatory T cells. Immunity,2012; 36: 873-884
    Google Scholar
  • 72. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A.,Bohlooly-Y M., Glickman J.N., Garrett W.S.: The microbial metabolites,short-chain fatty acids, regulate colonic Treg cell homeostasis.Science, 2013; 341: 569-573
    Google Scholar
  • 73. Spor A., Koren O., Ley R.: Unravelling the effects of the environmentand host genotype on the gut microbiome. Nat. Rev. Microbiol.,2011; 9: 279-290
    Google Scholar
  • 74. Stappenbeck T.S., Hooper L.V., Gordon J.I.: Developmental regulationof intestinal angiogenesis by indigenous microbes via Panethcells. Proc. Natl. Acad. Sci. USA, 2002; 99: 15451-15455
    Google Scholar
  • 75. Tomura M., Honda T., Tanizaki H., Otsuka A., Egawa G., TokuraY., Waldmann H., Hori S., Cyster J.G., Watanabe T., Miyachi Y., KanagawaO., Kabashima K.: Activated regulatory T cells are the majorT cell type emigrating from the skin during a cutaneous immuneresponse in mice. J. Clin. Invest., 2010; 120: 883-893
    Google Scholar
  • 76. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R.,Gordon J.I.: An obesity-associated gut microbiome with increasedcapacity for energy harvest. Nature, 2006; 444: 1027-1031
    Google Scholar
  • 77. Valins W., Amini S., Berman B.: The expression of Toll-like receptorsin dermatological diseases and the therapeutic effect ofcurrent and newer topical Toll-like receptor modulators. J. Clin.Aesthet. Dermatol., 2010; 3: 20-29
    Google Scholar
  • 78. van der Aar A.M., Picavet D.I., Muller F.J., de Boer L., van CapelT.M., Zaat S.A., Bos J.D., Janssen H., George T.C., Kapsenberg M.L.,van Ham S.M., Teunissen M.B., de Jong E.C.: Langerhans cells favorskin flora tolerance through limited presentation of bacterial antigensand induction of regulatory T cells. J. Invest. Dermatol., 2013;133: 1240-1249
    Google Scholar
  • 79. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., MwangiS., Srinivasan S., Sitaraman S.V., Knight R., Ley R.E., Gewirtz A.T.:Metabolic syndrome and altered gut microbiota in mice lackingToll-like receptor 5. Science, 2010; 328: 228-231
    Google Scholar
  • 80. Volz T., Skabytska Y., Guenova E., Chen K.M., Frick J.S., KirschningC.J., Kaesler S., Röcken M., Biedermann T.: Nonpathogenic bacteriaalleviating atopic dermatitis inflammation induce IL-10-producingdendritic cells and regulatory Tr1 cells. J. Invest. Dermatol., 2014;134: 96-104
    Google Scholar
  • 81. Wakkee M., Nijsten T.: Comorbidities in dermatology. Dermatol.Clin., 2009; 27: 137-147
    Google Scholar
  • 82. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B.,Feldstein A.E., Britt E.B., Fu X., Chung Y.M., Wu Y., Schauer P., SmithJ.D., Allayee H., Tang W.H., DiDonato J.A., Lusis A.J., Hazen S.L.: Gutflora metabolism of phosphatidylcholine promotes cardiovasculardisease. Nature, 2011; 472: 57-63
    Google Scholar
  • 83. Wanke I., Steffen H., Christ C., Krismer B., Götz F., Peschel A.,Schaller M., Schittek B.: Skin commensals amplify the innate immuneresponse to pathogens by activation of distinct signaling pathways.J. Invest. Dermatol., 2011; 131: 382-390
    Google Scholar
  • 84. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., StonebrakerA.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., Gordon J.I.,Chervonsky A.V.: Innate immunity and intestinal microbiota in thedevelopment of type 1 diabetes. Nature, 2008; 455: 1109-1113
    Google Scholar
  • 85. Whitfeld M., Gunasingam N., Leow L.J., Shirato K., Preda V.: Staphylococcusepidermidis: a possible role in the pustules of rosacea.J. Am. Acad. Dermatol., 2011; 64: 49-52
    Google Scholar
  • 86. Yamasaki K., Gallo R.L.: Antimicrobial peptides in human skindisease. Eur. J. Dermatol., 2008; 18: 11-21
    Google Scholar
  • 87. Yamasaki K., Kanada K., Macleod D.T., Borkowski A.W., MorizaneS., Nakatsuji T., Cogen A.L., Gallo R.L.: TLR2 expression is increasedin rosacea and stimulates enhanced serine protease production bykeratinocytes. J. Invest. Dermatol., 2011; 131: 688-697
    Google Scholar
  • 88. Yates V.M., Watkinson G., Kelman A.: Further evidence for anassociation between psoriasis, Crohn’s disease and ulcerative colitis.Br. J. Dermatol., 1982; 106: 323-330
    Google Scholar

Pełna treść artykułu

Przejdź do treści